Key Finding
Acupuncture combined with Chinese medicine significantly reduced cancer pain intensity and improved quality of life compared to standard care alone across 10 randomized controlled trials involving 884 patients.
Researchers reviewed 10 studies involving 884 cancer patients to determine whether combining acupuncture with Chinese herbal medicine could help reduce cancer pain. Cancer pain can result from the disease itself or from treatments like chemotherapy and radiation, and managing this pain remains a significant challenge for patients and healthcare providers.
The review found that patients who received both acupuncture and Chinese medicine experienced better pain relief compared to those who received other standard treatments. Seven of the studies showed a reduction in pain intensity when these therapies were combined. Additionally, patients who received the combined treatment alongside pain medications experienced faster pain relief—the medications started working about 15 minutes sooner. The pain relief also lasted longer, extending by approximately 2.4 hours on average.
Beyond pain reduction, five studies demonstrated that this combined approach improved patients' overall quality of life. The research suggests that acupuncture and Chinese medicine work well together, potentially offering cancer patients a complementary option to help manage their pain alongside conventional treatments.
While these findings are encouraging, it's important to note that this review included studies of varying quality, and more high-quality research is needed to confirm these benefits. The studies were conducted primarily in clinical settings where practitioners were experienced in both acupuncture and Chinese herbal medicine.
If you're considering acupuncture for cancer pain, consult with your oncology team first and seek treatment from a licensed acupuncturist with experience in oncology support care.
This systematic review and meta-analysis evaluated 10 RCTs (n=884) examining acupuncture combined with Chinese medicine versus standard care for cancer pain management. Seven trials demonstrated significant reduction in pain intensity. Pooled analysis of 6 RCTs showed improved analgesic efficacy (MD=1.22; 95% CI 1.12-1.32; I²=13%). Two trials reported shortened analgesic onset time (MD=-14.82 minutes; 95% CI -16.80 to -12.82; I²=0%), while 3 trials showed increased analgesia duration (MD=2.40 hours; 95% CI 2.01-3.82; I²=95%). Five RCTs demonstrated quality of life improvements (MD=4.68; 95% CI 3.69-5.66; I²=0%). Risk of bias assessment used Cochrane tools with RevMan 5.4. Clinical takeaway: Combined acupuncture and Chinese medicine demonstrates statistically significant benefits for cancer pain reduction, analgesic optimization, and quality of life improvement compared to conventional care alone, supporting integration as adjunctive therapy in oncology pain management protocols.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 6-week integrative Korean medicine treatment centered on high-dose Angelica gigas produced clinically significant improvements in pain, function, and quality of life in a patient with 10-year treatment-refractory fibromyalgia unresponsive to opioid therapy.
📌 SSRIs significantly reduced pain and depression in fibromyalgia compared to placebo, but showed no significant advantage over non-pharmacological interventions including acupuncture for treating depression.
📌 Left-sided auricular vagus nerve stimulation reduced pro-inflammatory cytokines and increased anti-inflammatory markers and BDNF in women with fibromyalgia, despite not producing superior pain relief compared to sham treatment.